MAPT and ischemia: In addition, the contribution of GLN to the alleviation of various brain pathologic scenarios has been previously shown—it potentially acts by suppressing inflammatory cascades in animal models of autoimmune encephalomyelitis [27] and ischemia [28,30] and reducing the phosphorylation of the Tau protein in a brain ischemia-reperfusion model [29].